IMCR financials
Immunocore (IMCR) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
IMCR income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $297.57M | $291.36M | -$33.74M | -$26.42M | -0.53 |
| 2024 | $247.98M | $242.44M | -$56.28M | -$40.81M | -1.02 |
| 2023 | $197.39M | $196.57M | -$47.20M | -$43.75M | -0.89 |
| 2022 | $144.23M | $138.94M | -$42.77M | -$43.46M | -0.95 |
| 2021 | $27.04M | $27.04M | -$129.42M | -$133.45M | -3.00 |
| 2020 | $30.11M | -$44.70M | -$86.19M | -$74.09M | -2.33 |
- IMCR revenue was $297.57M in fiscal 2025, net income -$26.42M.
Updated 2026-11-07 11:56 UTC